Location History:
- Jiangsu, CN (2018)
- Shanghai, CN (2015 - 2023)
Company Filing History:
10 out of 10 
2 out of 3,923 
1 out of 2 Years Active: 2015-2025
Introduction
Hongping Yu, an accomplished inventor based in Shanghai, China, is known for his significant contributions to the field of cancer treatment through innovative compounds. With a remarkable portfolio of 11 patents, Yu is recognized for his pioneering work in developing inhibitors that play crucial roles in combating various cancers and related diseases.
Latest Patents
Among Hongping Yu's latest patents are groundbreaking inventions aimed at tackling tumors and cancers. His patent for an FGFR inhibitor includes a compound identified by a specific structure, along with its preparation method and applications. This compound serves as an FGFR inhibitor that potentially treats tumors, various cancers, myeloproliferative diseases, bone or chondrocyte disorders, and hypophosphatemia.
Another noteworthy invention is his CD73 inhibitor, which demonstrates potential in treating cancers or tumors associated with CD73, as well as autoimmune diseases and metabolic disorders. This innovative series of compounds promises to provide valuable therapeutic options for melanoma, colon cancer, pancreatic cancer, breast cancer, prostate cancer, lung cancer, leukemia, brain tumors, lymphoma, ovarian cancer, and Kaposi's sarcoma. The anticipated development of a new generation of CD73 inhibitor drugs underscores Yu’s impact in the field.
Career Highlights
Hongping Yu's career is distinguished by his tenure at leading pharmaceutical companies, including Abbisko Therapeutics Co., Ltd and Novartis AG. His experiences at these organizations have equipped him with the expertise to translate scientific knowledge into tangible therapeutic solutions, fostering advancements in cancer treatment.
Collaborations
Collaborating with talented professionals such as Zhui Chen and Yaochang Xu, Hongping Yu has played a vital role in multidisciplinary teams, striving toward the common goal of innovation in medical treatments. These collaborations have enriched his research and development initiatives, enhancing the potential impact of his work.
Conclusion
In summary, Hongping Yu stands out as a pivotal inventor in the realm of cancer therapeutics. His innovative patents, particularly in FGFR and CD73 inhibitors, reflect his commitment to improving treatment options for various cancers. Through collaborative efforts and extensive experience in reputable companies, Yu continues to make significant strides in the field of medical innovation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.